- Home
- ONL vs ALEC Comparison
ONL vs ALEC Comparison
Compare ONL & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONL
- ALEC
- Stock Information
- Founded
- ONL 2021
- ALEC 2013
- Country
- ONL United States
- ALEC United States
- Employees
- ONL N/A
- ALEC N/A
- Industry
- ONL Real Estate Investment Trusts
- ALEC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ONL Real Estate
- ALEC Health Care
- Exchange
- ONL Nasdaq
- ALEC Nasdaq
- Market Cap
- ONL 111.3M
- ALEC 124.0M
- IPO Year
- ONL N/A
- ALEC 2019
- Fundamental
- Price
- ONL $1.93
- ALEC $1.38
- Analyst Decision
- ONL Hold
- ALEC Buy
- Analyst Count
- ONL 1
- ALEC 7
- Target Price
- ONL N/A
- ALEC $4.70
- AVG Volume (30 Days)
- ONL 636.5K
- ALEC 1.2M
- Earning Date
- ONL 05-07-2025
- ALEC 05-08-2025
- Dividend Yield
- ONL 4.12%
- ALEC N/A
- EPS Growth
- ONL N/A
- ALEC N/A
- EPS
- ONL N/A
- ALEC N/A
- Revenue
- ONL $154,796,000.00
- ALEC $88,339,000.00
- Revenue This Year
- ONL N/A
- ALEC N/A
- Revenue Next Year
- ONL N/A
- ALEC $392.45
- P/E Ratio
- ONL N/A
- ALEC N/A
- Revenue Growth
- ONL N/A
- ALEC N/A
- 52 Week Low
- ONL $1.46
- ALEC $0.87
- 52 Week High
- ONL $4.39
- ALEC $6.78
- Technical
- Relative Strength Index (RSI)
- ONL 52.17
- ALEC 57.88
- Support Level
- ONL $1.63
- ALEC $1.01
- Resistance Level
- ONL $1.97
- ALEC $1.46
- Average True Range (ATR)
- ONL 0.11
- ALEC 0.12
- MACD
- ONL 0.01
- ALEC 0.02
- Stochastic Oscillator
- ONL 54.77
- ALEC 82.22
About ONL Orion Office REIT Inc.
Orion Properties Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased on a single-tenant net lease basis to creditworthy clients. The portfolio of the company includes traditional office buildings, governmental offices, medical offices, laboratories, and others. The Company operates in one business segment: direct ownership and operation of commercial real estate.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.